Elranatamab-Bcmm (Anti-BCMA & CD3)
£485.25
Elranatamab-Bcmm (Anti-BCMA & CD3) (A4010-1mg)
Product
| Cat # A4010-1mg | Size 1mg |
Price
£485.25
|
Qty
|
Description
Elranatamab-bcmm is a bispecific T-cell engager (BiTE) monoclonal antibody that targets CD3 and B-cell maturation antigen (BCMA), promoting the recruitment and activation of T cells to effectively eliminate malignant myeloma cells. It is FDA-approved for the treatment of adults with relapsed or refractory multiple myeloma. MW: 145.44 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Product Size | 1mg |
| Manufacturer Cat# | A4010 |
| Target | CD markers |